Literature DB >> 16914535

Proteinuria with and without renal glomerular podocyte effacement.

Raghu Kalluri1.   

Abstract

Renal biopsies of patients with proteinuria and kidney disease most often are associated with podocyte foot process effacement. For several decades, nephrologists have wondered whether proteinuria is a result of podocyte foot process effacement or the cause of it. In the past few years, the author's laboratory has addressed this issue using different mouse models of proteinuria. Although in most cases, podocyte effacement is associated with proteinuria and glomerular disease, in three different mouse models, it was demonstrated that proteinuria can be observed without podocyte foot process effacement. The first model is generated by injection of antibodies to vascular endothelial growth factor or soluble vascular endothelial growth factor receptor 1. The second model is a mouse with deletion of type IV collagen alpha3 chain in the glomerular basement membrane. The third model was generated by genetic deletion of a slit diaphragm protein known as nephrin. Collectively, these experiments and the supporting evidence from several human studies demonstrate that severe defects in either the glomerular basement membrane or the glomerular endothelium can lead to proteinuria without foot process effacement.

Entities:  

Mesh:

Year:  2006        PMID: 16914535     DOI: 10.1681/ASN.2006060628

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  25 in total

1.  Proteinuria: is it all in the foot?

Authors:  Pierre Ronco
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

2.  Solute partitioning and filtration by extracellular matrices.

Authors:  William H Fissell; Christina L Hofmann; Nicholas Ferrell; Lisa Schnell; Anna Dubnisheva; Andrew L Zydney; Peter D Yurchenco; Shuvo Roy
Journal:  Am J Physiol Renal Physiol       Date:  2009-07-08

Review 3.  Endothelin and the glomerulus in chronic kidney disease.

Authors:  Matthias Barton; Andrey Sorokin
Journal:  Semin Nephrol       Date:  2015-03       Impact factor: 5.299

4.  VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.

Authors:  Krista Heinolainen; Sinem Karaman; Gabriela D'Amico; Tuomas Tammela; Raija Sormunen; Lauri Eklund; Kari Alitalo; Georgia Zarkada
Journal:  Circ Res       Date:  2017-03-15       Impact factor: 17.367

Review 5.  Glomerular proteinuria: a complex interplay between unique players.

Authors:  Puneet Garg; Ton Rabelink
Journal:  Adv Chronic Kidney Dis       Date:  2011-07       Impact factor: 3.620

6.  Bacterial lipopeptide triggers massive albuminuria in murine lupus nephritis by activating Toll-like receptor 2 at the glomerular filtration barrier.

Authors:  Rahul D Pawar; Liliana Castrezana-Lopez; Ramanjaneyulu Allam; Onkar P Kulkarni; Stephan Segerer; Ewa Radomska; Tobias N Meyer; Catherine-Meyer Schwesinger; Nese Akis; Hermann-Josef Gröne; Hans-Joachim Anders
Journal:  Immunology       Date:  2008-10-24       Impact factor: 7.397

7.  Podocin inactivation in mature kidneys causes focal segmental glomerulosclerosis and nephrotic syndrome.

Authors:  Géraldine Mollet; Julien Ratelade; Olivia Boyer; Andrea Onetti Muda; Ludivine Morisset; Tiphaine Aguirre Lavin; David Kitzis; Margaret J Dallman; Laurence Bugeon; Norbert Hubner; Marie-Claire Gubler; Corinne Antignac; Ernie L Esquivel
Journal:  J Am Soc Nephrol       Date:  2009-08-27       Impact factor: 10.121

Review 8.  The Genetics of Nephrotic Syndrome.

Authors:  Michelle N Rheault; Rasheed A Gbadegesin
Journal:  J Pediatr Genet       Date:  2015-08-13

9.  Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes.

Authors:  Elena Tarabra; Sara Giunti; Federica Barutta; Gennaro Salvidio; Davina Burt; Giacomo Deferrari; Roberto Gambino; Daniela Vergola; Silvia Pinach; Paolo Cavallo Perin; Giovanni Camussi; Gabriella Gruden
Journal:  Diabetes       Date:  2009-07-08       Impact factor: 9.461

10.  Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy.

Authors:  Federica Barutta; Alessandro Corbelli; Raffaella Mastrocola; Roberto Gambino; Vincenzo Di Marzo; Silvia Pinach; Maria Pia Rastaldi; Paolo Cavallo Perin; Gabriella Gruden
Journal:  Diabetes       Date:  2010-01-12       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.